CMAX(CMAX)
CMAX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.38B | $1.23B | $1.42B |
| Low | $1.38B | $1.23B | $1.42B |
| High | $1.38B | $1.23B | $1.42B |
| EBITDA Avg | $-161M | $-143M | $-165M |
| Low | $-161M | $-143M | $-165M |
| High | $-161M | $-143M | $-165M |
| EBIT Avg | $-204M | $-182M | $-210M |
| Low | $-204M | $-182M | $-210M |
| High | $-204M | $-182M | $-210M |
| Net Income Avg | $-18M | $-26M | $-22M |
| Low | $-18M | $-26M | $-22M |
| High | $-18M | $-26M | $-22M |
| EPS Avg | $-4.95 | $-6.86 | $-6.02 |
| Low | $-4.95 | $-6.86 | $-6.02 |
| High | $-4.95 | $-6.86 | $-6.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $335M | $332M |
| Low | $335M | $332M |
| High | $335M | $332M |
| EBITDA Avg | $-39M | $-39M |
| Low | $-39M | $-39M |
| High | $-39M | $-39M |
| EBIT Avg | $-49M | $-49M |
| Low | $-49M | $-49M |
| High | $-49M | $-49M |
| Net Income Avg | $-5M | $-4M |
| Low | $-5M | $-4M |
| High | $-5M | $-4M |
| EPS Avg | $-1.32 | $-0.94 |
| Low | $-1.32 | $-0.94 |
| High | $-1.32 | $-0.94 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |